Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0154252002
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Approved | 02550970 | ACCORD HEALTHCARE INC | ADHEROZA | Human | Yes | Prescription | 1 | TRASTUZUMAB | 150 MG / VIAL |
Approved | 02550970 | ACCORD HEALTHCARE INC | ADHEROZA | Human | Yes | Schedule D | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02506211 | CELLTRION INC. | HERZUMA | Human | Yes | Schedule D | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02506211 | CELLTRION INC. | HERZUMA | Human | Yes | Prescription | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02518244 | AMGEN CANADA INC | KANJINTI | Human | Yes | Prescription | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02518244 | AMGEN CANADA INC | KANJINTI | Human | Yes | Schedule D | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02474425 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | OGIVRI | Human | Yes | Prescription | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02474425 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | OGIVRI | Human | Yes | Schedule D | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02524317 | SAMSUNG BIOEPIS CO., LTD | ONTRUZANT | Human | Yes | Schedule D | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02524317 | SAMSUNG BIOEPIS CO., LTD | ONTRUZANT | Human | Yes | Prescription | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02483475 | PFIZER CANADA ULC | TRAZIMERA | Human | Yes | Prescription | 1 | TRASTUZUMAB | 150 MG / VIAL |
Marketed | 02483475 | PFIZER CANADA ULC | TRAZIMERA | Human | Yes | Schedule D | 1 | TRASTUZUMAB | 150 MG / VIAL |
Application information
Related information
Contact us
Version 4.0.3